Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review-Reference-Cited by-同舟云学术

Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review

Published:2018-07 Issue:4 Volume:32 Page:272-279
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Bertoletti Laurent^ORCID,Benhamou Ygal,Béjot Yannick,Marechaux Sylvestre,Cheggour Saida,Aleil Boris,Lellouche Nicolas,Dillinger Jean-Guillaume,Delluc Aurélien

Funder

Bristol-Myers Squibb

Pfizer Alliance

Pfizer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference74 articles.

1. The Worcester venous thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism;Spencer;J Gen Intern Med,2006

2. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality;Cohen;Thromb Haemost,2007

3. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in western France;Delluc;Thromb Haemost,2016

4. Venous thrombosis: a multicausal disease;Rosendaal;Lancet,1999

5. Hereditary thrombophilia;Khan;Thromb J,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should direct oral anticoagulants be used to treat protein C or S deficiency?;JAAPA;2023-07

2. Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review;Seminars in Thrombosis and Hemostasis;2022-09-05

3. Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review;Seminars in Thrombosis and Hemostasis;2022-09-02

4. Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia;Life;2022-06-28

5. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes;Thrombosis Research;2021-06